Atea Pharmaceuticals (AVIR)Director sold ~$1.02M

~$1.02M

Approx. value · 360K sh @ $2.85

452K

Holds after · shares reported

Traded

Dec 10, 2024

Filed

Dec 12, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Dec 10, 2024 · this disclosureInsiderDirector sold ~$1.02M of AVIR shares in the open market

What came next

1. Jan 15, 2025InsiderDirector purchased ~$48K of AVIR shares in the open market
2. Jan 16, 2025InsiderDirector purchased ~$34K of AVIR shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Atea Pharmaceuticals

For Atea Pharmaceuticals, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AVIR page.

Other recent filings by Franklin M Berger, Director

• SEC Form 4 at Retension Pharmaceuticals (RTSN)Oct 14, 2026
• SEC Form 4 at Atea Pharmaceuticals (AVIR)Jan 17, 2025
• SEC Form 4 at Atea Pharmaceuticals (AVIR)Jan 17, 2025

The full history of Franklin M Berger, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Atea Pharmaceuticals

• SEC Schedule 13GOct 6, 2026
• SEC Form 4May 22, 2026
• SEC Form 4Jan 17, 2025
• SEC Form 4Jan 17, 2025

Everything OQRO holds on this company is on its AVIR page.